N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-phenylethyl)benzamide

C34H37N5O5 — CID 46001421

IUPACN-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-phenylethyl)benzamide
SMILESCOc1cccc(C(=O)N(CCc2ccccc2)CC(=O)N2CCN(c3ccc(-c4ccc(OC)cc4OC)nn3)CC2)c1
InChIInChI=1S/C34H37N5O5/c1-42-27-11-7-10-26(22-27)34(41)39(17-16-25-8-5-4-6-9-25)24-33(40)38-20-18-37(19-21-38)32-15-14-30(35-36-32)29-13-12-28(43-2)23-31(29)44-3/h4-15,22-23H,16-21,24H2,1-3H3
InChIKeyDJHDTVXIQDFTPR-UHFFFAOYSA-N
MW595.70 g/mol
LogP4.20
Rot. Bonds11

About N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-phenylethyl)benzamide

N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-phenylethyl)benzamide (PubChem CID 46001421) has the molecular formula C34H37N5O5 and a molecular weight of 595.70 g/mol. Its IUPAC name is N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-phenylethyl)benzamide.

Molecular Properties

Compound NameN-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-phenylethyl)benzamide
PubChem CID46001421
Molecular FormulaC34H37N5O5
Molecular Weight595.70 g/mol
Exact Mass595.28
IUPAC NameN-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-phenylethyl)benzamide
SMILESCOc1cccc(C(=O)N(CCc2ccccc2)CC(=O)N2CCN(c3ccc(-c4ccc(OC)cc4OC)nn3)CC2)c1
InChIInChI=1S/C34H37N5O5/c1-42-27-11-7-10-26(22-27)34(41)39(17-16-25-8-5-4-6-9-25)24-33(40)38-20-18-37(19-21-38)32-15-14-30(35-36-32)29-13-12-28(43-2)23-31(29)44-3/h4-15,22-23H,16-21,24H2,1-3H3
InChIKeyDJHDTVXIQDFTPR-UHFFFAOYSA-N
XLogP4.20
TPSA97.33 Ų
H-Bond Donors
H-Bond Acceptors8
Rotatable Bonds11
Heavy Atoms44
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500595.70
LogP ≤ 54.20
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 108

Analyze N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-phenylethyl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-phenylethyl)benzamide?
The IUPAC name of N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-phenylethyl)benzamide (CID 46001421) is N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-phenylethyl)benzamide.
What is the SMILES notation for N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-phenylethyl)benzamide?
The canonical SMILES for N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-phenylethyl)benzamide is COc1cccc(C(=O)N(CCc2ccccc2)CC(=O)N2CCN(c3ccc(-c4ccc(OC)cc4OC)nn3)CC2)c1.
What is the InChIKey of N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-phenylethyl)benzamide?
The InChIKey is DJHDTVXIQDFTPR-UHFFFAOYSA-N. The full InChI is InChI=1S/C34H37N5O5/c1-42-27-11-7-10-26(22-27)34(41)39(17-16-25-8-5-4-6-9-25)24-33(40)38-20-18-37(19-21-38)32-15-14-30(35-36-32)29-13-12-28(43-2)23-31(29)44-3/h4-15,22-23H,16-21,24H2,1-3H3.
What are the key properties of N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-phenylethyl)benzamide?
N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-phenylethyl)benzamide has a molecular weight of 595.70 g/mol, XLogP of 4.20, 11 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-phenylethyl)benzamide is sourced from PubChem (CID 46001421), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).